Nestle branches out into skin care

JOHN HEILPRIN
Last updated 10:24 12/02/2014

Relevant offers

World

An era ends for Starbucks and Howard Schultz Former Australian economist James Shugg jailed over UK drug-fuelled sex parties A $5.1 trillion deal? Painter says he's richer than Gates, Buffett and Bezos How your bad shopping choices affect my loved ones in Bangladesh Who's that hidden on your Toblerone? Kiwi to take over as CEO of Carl's Jr parent company Comment: This may be the day the Trump trade died Uber pledges to fix 'cult of the individual' amid scandals 'People are just making things up' about share sale - Gerry Harvey Ferrari 70th Anniversary: Seven of the world's worst Ferraris

Swiss food and drink group Nestle is creating a new unit for medical skin treatments via a deal that reduces its stake in French cosmetics company L'Oreal.

The Vevey, Switzerland-based company said on Tuesday it would take full ownership of Swiss dermatology pharmaceuticals company Galderma, which had been a 50/50 joint venture with L'Oreal.

It will use Galderma's management to form a new unit called Nestle Skin Health SA.

Nestle is striving to reposition its food-and-beverage business more into the nutrition and wellness fields.

Galderma's business fits in that new mold.

"The future of skin health and dermatology is a buoyant market globally," Nestle chief executive Paul Bulcke said.

Galderma, a Swiss company created in 1981, sells products in 70 countries that treat skin diseases including acne, psoriasis and cancer. The deal is subject to regulatory approval.

As part of the complicated deal, which is valued at €6.5 billion ($10.7 billion), Nestle's stake in L'Oreal will fall from 29.4 per cent to 23.3 per cent.

L'Oreal will buy back €48.5 million of its own shares and then cancel them.

Nestle chairman Peter Brabeck-Letmathe said the deal did not mean the company was abandoning its involvement in L'Oreal.

"Nestle will continue to support the development of L'Oreal as in the past 40 years," he said.

Following the share buyback and cancellation, the Bettencourt Meyers family's stake in L'Oreal will increase from 30.6 per cent to 33.3 per cent.

Ad Feedback

- AP

Special offers

Featured Promotions

Sponsored Content